BR0100334A - Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante - Google Patents

Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante

Info

Publication number
BR0100334A
BR0100334A BR0100334-8A BR0100334A BR0100334A BR 0100334 A BR0100334 A BR 0100334A BR 0100334 A BR0100334 A BR 0100334A BR 0100334 A BR0100334 A BR 0100334A
Authority
BR
Brazil
Prior art keywords
resulting product
phase
compositions containing
release compositions
active
Prior art date
Application number
BR0100334-8A
Other languages
English (en)
Inventor
Elizabeth Molenda Ferrei Amado
Fernando Rafael De Souza
Original Assignee
Diffucap Chemobras Quimica E F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diffucap Chemobras Quimica E F filed Critical Diffucap Chemobras Quimica E F
Priority to BR0100334-8A priority Critical patent/BR0100334A/pt
Priority to DK02715321.2T priority patent/DK1578342T3/da
Priority to PCT/BR2002/000001 priority patent/WO2002102129A2/en
Priority to PT02715321T priority patent/PT1578342E/pt
Priority to EP02715321A priority patent/EP1578342B1/en
Priority to AT02715321T priority patent/ATE442136T1/de
Priority to DE60233685T priority patent/DE60233685D1/de
Priority to MXPA03003530A priority patent/MXPA03003530A/es
Priority to US10/476,714 priority patent/US7563456B2/en
Priority to ES02715321T priority patent/ES2333302T3/es
Priority to AU2002224680A priority patent/AU2002224680A1/en
Publication of BR0100334A publication Critical patent/BR0100334A/pt
Priority to CY20091101265T priority patent/CY1109535T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DE COMPOSIçõES DE LIBERAçãO PROGRAMADA CONTENDO VENLAFAXINA E O PRODUTO RESULTANTE". A partir do que, o produto resultante permite uma melhor absorção do princípio ativo e uma diminuição drástica dos efeitos adversos, em virtude da metodologia de preparação. A formulação compreende uma primeira etapa, na qual se elaboram os núcleos não ativos em forma de microgrânulos esféricos, a partir de açúcar e amido. Na segunda etapa, agrega-se-lhes a droga ativa, na forma de pó impalpável, utilizando, como ligante, uma solução alcoólica de povidona. Na terceira etapa, aplica-se o recobrimento sobre os microgrânulos que contém a droga ativa. Finalmente, na quarta etapa, realiza-se o encapsulamento do microgrânulo recoberto.
BR0100334-8A 2001-01-17 2001-01-17 Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante BR0100334A (pt)

Priority Applications (12)

Application Number Priority Date Filing Date Title
BR0100334-8A BR0100334A (pt) 2001-01-17 2001-01-17 Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante
AT02715321T ATE442136T1 (de) 2001-01-17 2002-01-03 Verfahren zur herstellung einer zusammensetzung mit venlafaxin mit programmierter freisetzung und das resultierende produkt
PCT/BR2002/000001 WO2002102129A2 (en) 2001-01-17 2002-01-03 Process for the preparation of programmed liberation compositions with venlafaxine and the resulting product
PT02715321T PT1578342E (pt) 2001-01-17 2002-01-03 Processo para a preparação de uma composição de libertação programada com venlafaxina e produto resultante
EP02715321A EP1578342B1 (en) 2001-01-17 2002-01-03 Process for preparation of programmed liberation composition with venlafaxine and the resulting product
DK02715321.2T DK1578342T3 (da) 2001-01-17 2002-01-03 Fremgangsmåde til fremstilling af sammensætning med venlafaxin til kontrolleret frigørelse og det resulterende produkt
DE60233685T DE60233685D1 (de) 2001-01-17 2002-01-03 Verfahren zur herstellung einer zusammensetzung mis resultierende produkt
MXPA03003530A MXPA03003530A (es) 2001-01-17 2002-01-03 Procedimiento para la preparacion de composiciones de liberacion programada conteniendo venlafaxina y el producto resultante.
US10/476,714 US7563456B2 (en) 2001-01-17 2002-01-03 Process for preparation of programmed liberation composition with venlafaxine and the resulting product
ES02715321T ES2333302T3 (es) 2001-01-17 2002-01-03 Procedimiento de preparacion de una composicion de liberacion programada con venlafaxina y el producto resultante.sp.
AU2002224680A AU2002224680A1 (en) 2001-01-17 2002-01-03 Process for the preparation of programmed liberation compositions with venlafaxine and the resulting product
CY20091101265T CY1109535T1 (el) 2001-01-17 2009-12-01 Μεθοδος για παρασκευη συνθεσης προγραμματισμενης απελευθερωσης με βενλαφαξινη και το προκυπτον προϊον

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0100334-8A BR0100334A (pt) 2001-01-17 2001-01-17 Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante

Publications (1)

Publication Number Publication Date
BR0100334A true BR0100334A (pt) 2002-09-24

Family

ID=37734022

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0100334-8A BR0100334A (pt) 2001-01-17 2001-01-17 Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante

Country Status (12)

Country Link
US (1) US7563456B2 (pt)
EP (1) EP1578342B1 (pt)
AT (1) ATE442136T1 (pt)
AU (1) AU2002224680A1 (pt)
BR (1) BR0100334A (pt)
CY (1) CY1109535T1 (pt)
DE (1) DE60233685D1 (pt)
DK (1) DK1578342T3 (pt)
ES (1) ES2333302T3 (pt)
MX (1) MXPA03003530A (pt)
PT (1) PT1578342E (pt)
WO (1) WO2002102129A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0100334A (pt) * 2001-01-17 2002-09-24 Diffucap Chemobras Quimica E F Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
AU2003226752A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Venlafaxine base
WO2003094899A1 (es) * 2002-05-09 2003-11-20 Diffucap-Chemobras Química E Farmacéutica, Ltda. Nuevo procedimiento para la preparacion de composiciones de liberacion programada conteniendo (s) -1- [n-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-l-proline, y al producto obtenido por dicho procedimiento
CA2507685A1 (en) * 2002-11-28 2004-06-10 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci
EP1502587B1 (en) 2003-07-30 2006-08-23 Pharmathen S.A. Sustained release formulation for Venlafaxine hydrochloride
US20090175934A1 (en) * 2006-03-08 2009-07-09 Jubilant Organosys Ltd. Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same
US20070248669A1 (en) * 2006-04-25 2007-10-25 Fang-Hsiung Hsiao Oral sustained release formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
EP0113373B1 (en) * 1982-07-09 1991-08-28 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
US6001848A (en) * 1996-03-25 1999-12-14 The Regents Of The University Of California Bromocriptine for the treatment of alcoholics diagnosed with the D2 dopamine receptor DRD2 A1 allele
DE60035579T2 (de) * 1999-05-20 2008-04-17 Elan Corp. Plc Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
BR0100334A (pt) * 2001-01-17 2002-09-24 Diffucap Chemobras Quimica E F Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante

Also Published As

Publication number Publication date
US20040131677A1 (en) 2004-07-08
ES2333302T3 (es) 2010-02-19
WO2002102129A2 (en) 2002-12-27
DK1578342T3 (da) 2010-01-18
PT1578342E (pt) 2009-12-15
US7563456B2 (en) 2009-07-21
AU2002224680A1 (en) 2003-01-02
MXPA03003530A (es) 2005-01-25
WO2002102129A3 (en) 2006-12-07
AU2002224680A8 (en) 2007-02-01
EP1578342B1 (en) 2009-09-09
CY1109535T1 (el) 2014-08-13
DE60233685D1 (de) 2009-10-22
EP1578342A2 (en) 2005-09-28
ATE442136T1 (de) 2009-09-15

Similar Documents

Publication Publication Date Title
CY1109535T1 (el) Μεθοδος για παρασκευη συνθεσης προγραμματισμενης απελευθερωσης με βενλαφαξινη και το προκυπτον προϊον
WO2006125620A3 (en) Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
PT1439829E (pt) Medicamento contendo 3-(3-dimetilamino-1-etil-2-metilpropil)-fenol proporcionando libertacao retardada da substancia activa
NO20064934L (no) Fremgangsmate for fremstilling av et fast, farmasoytisk preparat
WO2004012699A3 (en) Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent
PT1401445E (pt) Anticolinergico cristalino, processo para a sua preparacao e sua utilizacao para a preparacao de um medicamento
CA2481848A1 (en) Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation
BR0012250A (pt) Processo de fabricação de grânulos revestidos com gosto mascarado, e liberação imediata do princìpio ativo, grânulo revestido, comprimido multiparticulado de dissolução rápida e comprimido de hidrodispersibilidade rápida
ATE344022T1 (de) Proinsulin c-peptid enthaltende arzneizubereitung mit verzögerter wirkstofffreigabe
BRPI0401779A (pt) Combinações adesivas ricas em corpos sólidos para lacas de cobertura estáveis ao risco
BR0011999A (pt) Formas de dosagem farmacêutica para liberação controlada produzindo pelo menos um pulso cronometrado
WO2007117550A3 (en) Methods for coacervation induced liposomal encapsulation and formulations thereof
WO2006092409A3 (en) Fast-release microcapsule products
JP2010540547A5 (pt)
WO2004066925A3 (en) Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
CA2450093A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
BR0214559A (pt) sais de ácido succìnico do 5,8,14-triazatetraciclo [10.3.1.0<2,11>.0<4,9>]-hexadeca-2(11),3,5,7,9-penteno e suas composições farmacêuticas
FR2894143B1 (fr) Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.
WO2003057150A3 (en) A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
WO2010026467A3 (en) Controlled release tablet of a highly water soluble active agent such as levetiracetam, or citicoline
WO2006069154A3 (en) Vitamin d receptor modulators
ES2095045T3 (es) Composiciones y procedimientos para la liberacion sostenida de medicamentos.
BR0206964A (pt) Diamidas de ácido ftálico, um processo para a sua preparação e sua aplicação como composições praguicidas
BR0314838A (pt) Sistema de liberação controlada, e, processo para preparar comprimidos de liberação controlada de temozolomida
BR0209834A (pt) Produto granulado fundido, processo para a preparação do mesmo, composição, e, forma de dosagem unitária farmacêutica moldada sólida

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.